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Background: Large-scale cohort studies are needed to confirm the relation between dementia 
and its possible risk factors. The inclusion of people with dementia in research is a challenge, 
however, children of people with dementia are at risk and are highly motivated to participate in 
dementia research. For technologies to support home-based data collection during large-scale 
studies, participants should be able and willing to use technology for a longer period of time.
Objective: This study investigated acceptance and usability of iVitality, a research platform for 
home-based monitoring of dementia health indicators, in 151 children of people with dementia 
and investigated which frequency of measurements is acceptable for them.
Methods: Participants were randomized to fortnightly or monthly measurements. At baseline and 
after 3 months, participants completed an online questionnaire regarding the acceptance (Tech-
nology Acceptance Model; 38 items) and usability (Post-Study System Usability Questionnaire; 
24 items) of iVitality. Items were rated from 1 (I totally disagree) to 7 (I totally agree). Partici-
pants were also invited to take part in an online focus group (OFG) after 3 months of follow-up. 
Descriptive statistics and both two-sample/independent and paired t-tests were used to analyze 
the online questionnaires and a directed content analysis was used to analyze the OFGs.
Results: Children of people with dementia accept iVitality after long-term use and evaluate 
iVitality as a user-friendly, useful, and trusted technology, despite some suggestions for 
improvement. Overall, mean scores on acceptance and usability were higher than 5 (I somewhat 
agree), although the acceptance subscales “social influence” and “time” were rated somewhat 
lower. No significant differences in acceptance and usability were found between both protocol 
groups. Over time, “affect” significantly increased among participants measuring blood pres-
sure fortnightly.
Conclusion: iVitality has the potential to be used in large-scale studies for home-based moni-
toring of health indicators related to the development of dementia.
Keywords: dementia, risk factors, e-health, telemonitoring, acceptance, usability
Plain language summary
To confirm the relation between dementia and possible risk factors, it is important to conduct 
studies among people with dementia with long follow-up periods. However, including people 
with dementia is difficult. Therefore, people at risk of developing dementia such as children of 
patients with dementia, could be included since they seem to be highly motivated to participate 
in research. Technologies can support the monitoring of possible risk factors of dementia. Before 
such technologies can be included in studies regarding the relation between dementia and its 
risk factors, it should be investigated whether participants are able and willing to use such 
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technologies for a long duration. This study shows that children 
of people with dementia accept the long-term use of iVitality, a 
monitoring tool measuring risk factors of dementia, based on online 
questionnaires and focus groups. The rate of acceptance did not 
differ between those measuring risk factors of dementia fortnightly 
or monthly. Therefore, we conclude that iVitality has the potential 
to be used for home-based monitoring of risk factors of dementia.
Introduction
The number of people who suffer from dementia is expected 
to increase rapidly in the coming years.1 Despite increased 
understanding of the causes of dementia, no cure or effective 
preventive interventions are available yet. Previous research 
suggests that interventions that aim to influence risk factors, 
such as uncontrolled blood pressure (BP), low mental and 
physical activity (AC), and obesity, could play a role in pre-
venting dementia.2 Large-scale cohort studies with long-term 
follow-up are needed to confirm the relation between these 
risk factors and the onset of dementia. However, research 
which aims to study the preventive strategies that influence 
these risk factors needs to start before the onset of dementia 
and needs to include very large samples of older adults. 
This is a challenge in the field of research, including people 
with dementia. The inclusion of people with dementia in 
long-term follow-up studies is difficult due to deteriorating 
prognoses or even death. Furthermore, selecting a sample 
from the general population would require a large number of 
participants due to their relatively “low” risk of developing 
dementia. Therefore, we chose to recruit children of people 
with dementia, who have an increased risk of developing 
hypertension and dementia.3,4 Moreover, they are highly 
motivated to contribute to research about the prevention of 
dementia, because of their direct experiences with the impact 
of dementia.5,18
Technologies such as internet, smartphones, computers, 
sensors, and home-based monitoring devices can be used to 
support data collection during large-scale clinical studies. 
Such technologies are also increasingly used by middle-aged 
and older adults which provides opportunities to include 
them in research.6 If these technologies can facilitate par-
ticipant recruitment and data collection, this can contribute 
to the development and study of evidence-based preventive 
strategies and treatment for the ageing population, including 
people with dementia.
iVitality is a research platform, consisting of a website, 
a smartphone-based application, and sensors which are con-
nected to the smartphone. iVitality can be used for home-
based long-term monitoring of several health indicators, 
ie, BP, AC, cognition (C), and lifestyle factors, that are 
associated with dementia, as shown in previous research.5,7–9 
iVitality is intended to be used in the PROBE (PReserva-
tion Of Brian function in the Elderly) study, a large-scale 
trial on these health indicators and their relationship with 
dementia. In order to support such large-scale clinical studies 
regarding the etiology of dementia and potentially relevant 
prevention strategies, participants of such studies should be 
able and willing to use the platform for a longer period of 
time. Factors such as the usability of the platform, clearness 
of its interface, and its functional/technical adequacy might 
influence participants’ willingness to use the platform.10 
Furthermore, the frequency of health indicator measurements 
might influence participants’ intention to use the platform.11 
Therefore, the objectives of this Proof of Principle (POP) 
study are to gain insight into the long-term acceptance and 
usability of iVitality according to children of people with 
dementia, and to find out which frequency of measurements 
is acceptable for them.
Methods
Design and participants
The POP study had 6 months of follow-up. Potential partici-
pants were recruited via posters and flyers in memory clinics 
to reach children of people with dementia, who accompanied 
their parent to the memory clinic. Furthermore, potential 
participants were recruited via advertisements in the maga-
zine and on the website of the Dutch Alzheimer Associa-
tion. Participants were eligible for inclusion if they: 1) were 
children of people with late-onset dementia diagnosed as 
Alzheimer’s disease, vascular dementia or mixed dementia, 
2) were aged between 45 and 75 years old, 3) had no prior 
diagnosis of hypertension, and 4) were in possession of a 
smartphone with iOS or Android software (version 2.3.3. 
or higher). Children of people with dementia who wanted to 
take part in the POP study registered via the iVitality website. 
This website provided information about the study and after 
reading this information 195 participants registered online to 
participate. This study was approved by the Medical Ethical 
Committee of LUMC, the Netherlands (P11.131).
Procedures and measurements
A baseline (T1) assessment with a nurse practitioner or 
medical doctor from one of the participating memory clinics 
was scheduled with 151 participants who provided informed 
consent and were included in the study, based on the inclusion 
criteria. During this appointment, participants’ office BP was 
measured and basic demographic characteristics, medication 
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use, and medical history were recorded. Also, participants 
received an explanation about how to download the iVitality 
application on their own smartphone and how to use iVitality 
during the POP study. If necessary, they practiced this with 
the nurse practitioner. A BP measurement instrument was 
provided to all participants for the duration of the study. After 
participants downloaded the iVitality application they were 
randomly assigned to one of the two measurement protocols. 
Randomization was stratified for gender and performed in a 
1:1 manner. Table 1 shows the measurement sequences of BP 
monitoring, AC monitoring, and C tests, and lifestyle ques-
tions (Q) of protocol 1 and protocol 2. For both protocols, 
AC, C, and lifestyle were measured on 4 consecutive days 
in the first and final week of the study. In addition, C and 
lifestyle were measured for 1 day each week in-between the 
first and final week. Differences between protocol groups 
concerned the frequency of BP measurement, which was 
measured monthly (on 2 consecutive days) for protocol 1 
and fortnightly (on only 1 day) for protocol 2. A 1-day BP 
measurement consisted of two consecutive measurements 
in the morning and two in the evening. Via the iVitality 
application, participants received notifications with regard to 
these measurements. Participants used iVitality for 6 months. 
All data regarding BP, AC, C, and Q were automatically 
uploaded to a central database which was password protected. 
If hypertension was diagnosed (average BP of 135/85 mmHg 
based on multiple measurements) the study doctor received 
an automated notification and informed the participant to 
visit his/her general practitioner (GP).
All participants received an online questionnaire at 
T1 and after 3 months of follow-up (T2) which contained 
questions regarding the acceptance and usability of iVitality. 
In addition, participants who participated between 3 and 
6 months were invited to take part in an online focus groups 
(OFG) interview (T3) to gain insight into their experiences 
with the iVitality research platform.
Online questionnaires
An online questionnaire was used to measure the acceptance 
and usability of iVitality at T1 and T2. The questionnaire 
used to measure acceptance of iVitality was the Technology 
Acceptance Model (TAM) and its extensions developed by 
Venkatesch et al.12 The questionnaire consisted of 38 items 
divided over eight subscales: motivation (13 items), per-
formance expectancy (five items), effort expectancy (four 
items), social influence (two items), affect (four items), trust 
(four items), self-efficacy (five items), and time (one item). 
According to the TAM, these concepts influence a person’s 
intention to use a new technological innovation and by that the 
actual use in daily life.12 The complete acceptance question-
naire was included in the online questionnaire at T1 and T2. 
An adapted version of the Post-Study System Usability 
Questionnaire (PSSUQ) was used to measure usability 
of iVitality.10 This questionnaire consisted of 24 items divided 
over three subscales: system usefulness (nine items), informa-
tion quality (eight items), and interface quality (eight items). 
These 24 items were included in the online questionnaire at 
T1 and T2. All items of the online questionnaires regarding 
acceptance and usability were rated on a scale from 1 (I totally 
disagree) to 7 (I totally agree). Higher scores indicated higher 
acceptance and usability. In addition, a “not applicable” 
answer category was added to all items.
OFgs
OFGs are feasible tools for collecting qualitative data.13,14 
Two OFGs were conducted at T3 to collect user experiences 
with iVitality: one with participants, who were randomized to 
measurement protocol 1 (OFG 1), and one with participants, 
who were randomized to measurement protocol 2 (OFG 2). 
A web browser was used which could run on an MS Windows/
Web server platform. The OFGs took place in the last half of 
October 2014. All participants who had been using iVitality 
for at least 3 months at that moment were invited to take 
part in an OFG. Participants registered themselves and 
received a login and password from the moderator of the 
online platform (who was part of the research team) with 
which they could enter the OFG. Participants had access to 
the OFG platform for 2 weeks. During these 2 weeks, ten 
statements (one new statement on every weekday) regarding 
Table 1 sequences of health indicator measurements per 
protocol group
Week number Protocol 1 Protocol 2
1 (baseline) 4d BP, 4d Ac, 4d c+Q 4d BP, 4d Ac, 4d c+Q
3 1d c+Q 1d BP, 1d c+Q
5 2d BP, 1d c+Q 1d BP, 1d c+Q
7 1d c+Q 1d BP, 1d c+Q
9 2d BP, 1d c+Q 1d BP, 1d c+Q
11 1d c+Q 1d BP, 1d c+Q
13 2d BP, 1d c+Q 1d BP, 1d c+Q
15 1d c+Q 1d BP, 1d c+Q
17 2d BP, 1d c+Q 1d BP, 1d c+Q
19 1d c+Q 1d BP, 1d c+Q
21 2d BP, 1d c+Q 1d BP, 1d c+Q
23 1d c+Q 1d BP, 1d c+Q
25 4d BP, 4d Ac, 4d c+Q 4d BP, 4d Ac, 4d c + Q
Abbreviations: d, days; BP, blood pressure; Ac, physical activity; c, cognition; 
Q, lifestyle questions.
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the use and experiences with iVitality were posted by the 
moderator (Table 2). Participants were invited by the mod-
erator to respond to these statements and engage in an online 
discussion with each other. Participants could respond to all 
statements during the 2-week period at a time and place that 
was convenient for them. Consequently, communication 
between the participants was asynchronous. Participants 
were instructed not to mention any names for the sake of 
anonymity.
Analyses
Online questionnaires
Descriptive statistics were used to provide information on the 
T1 characteristics of the groups of participants assigned to 
measurement protocols 1 and 2. If participants filled out none 
of the items of the acceptance or usability questionnaire on 
T1, T2 or filled out all items with “not applicable”, they were 
excluded from the analyses. If participants filled out at least 
one question of both questionnaires, they were included in 
the analyses. In that case, missing items or “not applicable” 
answers on the questionnaire were imputed by the mean 
score of that item of all participants of the relevant measure-
ment protocol at the particular time point. Cronbach’s α was 
calculated for the subscales of the acceptance and usability 
questionnaire. Cronbach’s α of the following subscales was 
below 0.7: motivation, social influence, affect, self-efficacy, 
and time. Deleting items for the subscales motivation and 
affect did not result in substantial improvements in the alphas 
and therefore no items were deleted. No items could be deleted 
for social influence and time, since both subscales consisted 
of only one or two items. Deleting items for the subscale self-
efficacy did result in improvements in the alphas, however no 
items were deleted since mean scores of the subscale remained 
significantly unchanged after deleting items. Mean scores 
(SD) were calculated for subscales of the acceptance and 
usability questionnaires for both protocol groups separately. 
Independent samples t-tests were conducted to compare 
whether acceptance and usability was rated differently 
between both protocol groups. Paired samples t-tests were 
conducted to compare whether acceptance and usability was 
rated differently between measurement points (T1 and T2). 
All analyses were performed using SPSS version 23.
OFgs
The moderator of the OFGs analyzed the data of the OFGs 
using a directed content analysis approach. Data were ana-
lyzed per statement for the two OFGs separately, to be able 
to detect differences in the experiences of participants who 
followed different measurement protocols.
Results
Online questionnaires
Participant characteristics
In total, 151 participants were included in the POP 
study and randomly assigned to two measurement pro-
tocols: 66 participants were randomized to measurement 
protocol 1 and 85 were randomized to protocol 2. Sixteen 
participants were excluded (four protocol 1 and twelve 
protocol 2), since they completed none of the questions 
of the TAM or PSSUQ at both measurement points. The 
resulting 135 participants were included in the analyses of 
the online questionnaires at T1 and T2 (62 protocol 1 and 
73 protocol 2). T1 characteristics of these participants are 
provided in Table 3.
Missing items on the questionnaires of the included par-
ticipants were imputed. For the acceptance questionnaire, 
2.9% of the scores of all participants were imputed and 1.9% 
for the usability questionnaire. Overall, 2.5% of scores on 
the online questionnaires were imputed.
Acceptance and usability questionnaires
Table 4 shows the mean scores (SD) on the acceptance 
(motivation, performance expectancy, effort expectancy, 
Table 2 Ten statements of the online focus groups
Week 1
statement 1 iVitality fits into my daily life
statement 2 i would like to use iVitality for 2 more years after 
this study
statement 3 Contributing to scientific research is more important 
than gathering information about my health
statement 4 iVitality is a user-friendly system
statement 5 iVitality influenced my health and lifestyle
Week 2
statement 6 I am sufficiently able to use iVitality without help
statement 7 i would contact my general practitioner if my blood 
pressure was too high
statement 8 i think that my privacy was guaranteed during the 
use of iVitality
statement 9 i trust iVitality to accurately present my health data
statement 10 What would you like to change about the way you 
used iVitality during the study?
Table 3 Baseline characteristics of participants included in analyses 
of online questionnaires
Protocol 1  
(n=62)
Protocol 2  
(n=73)
Mean age in years (sD; min–max) 56.4 (4.9; 48–68) 57.8 (5.3; 49–72)
gender (female/male) 42/20 52/21
indication of hypertension  
during study without prior  
diagnosis (yes/no)
16/46 13/60
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social influence, affect, trust, self-efficacy, and time) and 
usability subscales (system usefulness, information quality, 
interface quality) at T1 and T2 for the two protocol groups 
separately. Table 4 also shows the t-scores and P-values of the 
independent samples t-tests which were conducted to compare 
the mean scores of both protocol groups at T1 and T2. The 
two-sample/independent t-tests revealed that there were no 
significant differences in acceptance and usability between 
both protocol groups. Overall, the mean scores on the accep-
tance and usability subscales were higher than 5 (I somewhat 
agree). The mean scores on the social influence and time 
subscale were somewhat lower for both protocol groups.
Mean scores of both protocol groups were also compared 
over time, eg, between measurement points T1 and T2. 
Table 5 shows the t-scores and P-values of the paired samples 
t-tests which were conducted. The paired t-tests revealed that 
scores on the effort expectancy subscale and social influence 
subscale significantly increased at T2 compared to T1 for 
both protocol groups. Mean scores on the affect subscale sig-
nificantly increased between T1 and T2 for protocol group 2, 
meaning that only participants measuring BP fortnightly 
showed more affect toward using iVitality at T2.
OFgs
Participant characteristics
In total, 32 participants registered for the OFGs and received 
a login and password. Eventually, 26 of them actively partici-
pated in an OFG: eleven in OFG 1 and 15 in OFG 2. Charac-
teristics of these participants are provided in Table 6.
Participant activity
In OFG 1 participants posted 71 reactions in total during 
the 2-week period and the number of reactions per partici-
pant varied between two and eleven. In OFG 2 participants 
posted 118 reactions in total during the 2-week period and 
the number of reactions per participant varied between three 
and eleven. The information in Table 7 shows that eight 
Table 5 comparison of mean acceptance and usability scores 
between baseline (T1) and after 3 months of follow-up (T2) per 
protocol group
T1 T2 Paired t-test
Mean (SD) Mean (SD) t P-value
Protocol 1 (n=62)
Motivation 5.09 (0.45) 5.10 (0.41) -0.13 0.90
Performance expectancy 5.03 (1.1) 5.05 (0.98) -0.14 0.89
effort expectancy 5.74 (1.01) 6.18 (0.92) -2.81 0.01*
Social influence 3.05 (1.23) 3.45 (1.25) -3.05 0.00*
Affect 5.61 (0.88) 5.71 (0.97) -0.88 0.38
Trust 5.95 (0.78) 6.04 (0.83) -0.93 0.37
Self-efficacy 5.36 (1.00) 5.48 (0.85) -1.10 0.28
Time 4.37 (0.99) 4.29 (0.88) 0.57 0.57
system usefulness 6.53 (0.78) 6.51 (0.63) 0.21 0.84
information quality 6.37 (0.74) 6.23 (1.00) 1.13 0.26
interface quality 6.23 (0.90) 6.09 (0.94) 1.36 0.18
Protocol 2 (n=73)
Motivation 4.97 (0.52) 5.03 (0.39) -0.95 0.34
Performance expectancy 4.72 (1.08) 4.70 (1.07) 0.20 0.84
effort expectancy 5.64 (0.94) 6.16 (1.03) -3.96 0.00*
Social influence 2.89 (1.10) 3.75 (1.29) -5.82 0.00*
Affect 5.48 (0.78) 5.74 (0.95) -2.46 0.02*
Trust 5.95 (0.82) 6.07 (0.79) -1.19 0.24
Self-efficacy 5.36 (0.87) 5.44 (0.94) -0.75 0.45
Time 4.14 (1.10) 4.18 (0.89) -0.32 0.75
system usefulness 6.60 (0.54) 6.59 (0.52) -0.02 0.99
information quality 6.47 (0.63) 6.35 (0.70) 1.51 0.14
interface quality 6.29 (0.82) 6.17 (0.90) 1.51 0.14
Note: *P0.05.
Table 6 characteristics of online focus group (OFg) participants
OFG 1 (n=11) OFG 2 (n=15)
Mean age in years (sD; min–max) 57.9 (5.2; 51–70) 59.3 (6.2; 52–70)
gender (female/male) 8/3 10/5
indication of hypertension  
during study without prior  
diagnosis (yes/no)
0/11 4/11
Table 4 comparison of mean acceptance and usability scores 
between protocol groups at baseline (T1) and after 3 months of 
follow-up (T2)
Protocol 1 
(n=62)
Protocol 2 
(n=73)
Two-sample/
independent 
t-test
Mean (SD) Mean (SD) t P-value
T1
Motivation 5.09 (0.45) 4.97 (0.52) 1.44 0.15
Performance expectancy 5.03 (1.1) 4.72 (1.08) 1.64 0.10
effort expectancy 5.74 (1.01) 5.64 (0.94) 0.59 0.56
Social influence 3.05 (1.23) 2.89 (1.10) 0.79 0.43
Affect 5.61 (0.88) 5.48 (0.78) 0.87 0.39
Trust 5.95 (0.78) 5.95 (0.82) 0.00 0.80
Self-efficacy 5.36 (1.00) 5.36 (0.87) -0.01 0.99
Time 4.37 (0.99) 4.14 (1.10) 1.29 0.20
system usefulness 6.53 (0.78) 6.60 (0.54) -0.66 0.51
information quality 6.37 (0.74) 6.47 (0.63) -0.90 0.37
interface quality 6.23 (0.90) 6.29 (0.82) -0.38 0.70
T2
Motivation 5.10 (0.41) 5.03 (0.39) 1.05 0.30
Performance expectancy 5.05 (0.98) 4.70 (1.07) 1.94 0.06
effort expectancy 6.18 (0.92) 6.16 (1.03) 0.11 0.91
Social influence 3.45 (1.25) 3.75 (1.29) -1.36 0.18
Affect 5.71 (0.97) 5.74 (0.95) -0.16 0.87
Trust 6.04 (0.83) 6.07 (0.79) -0.19 0.85
Self-efficacy 5.48 (0.85) 5.44 (0.94) 0.28 0.78
Time 4.29 (0.88) 4.18 (0.89) 0.70 0.48
system usefulness 6.51 (0.63) 6.59 (0.52) -0.84 0.40
information quality 6.23 (1.00) 6.35 (0.70) -0.86 0.39
interface quality 6.09 (0.94) 6.17 (0.90) -0.50 0.62
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participants (two in OFG 1 and six in OFG 2) responded to 
all statements whereas one participant (in OFG 1) responded 
only to two statements. Overall, the frequency of reactions on 
the forum decreased after week 1 in both groups. Reactions 
of participants in OFG 2 were more elaborate compared to 
reactions of participants of OFG 1. In cases of participants 
replying to each other’s reactions, instead of only voicing 
their opinion regarding the statement which was posted, they 
mostly agreed with each other.
Participant experiences with iVitality
Overall, participants in OFG 1 and OFG 2 agreed on most 
of the ten statements. Participants agreed that iVitality could 
be incorporated in their daily lives, although they preferred 
more flexible measurement moments and measurements 
outside their houses were difficult: “iVitality only fits use at 
home. I did not want to carry the BP device outdoors, which 
has led to some missing values” (protocol 1). Participants in 
both focus groups indicated that they had sufficient skills to 
use iVitality without help, although help being available was 
perceived as pleasant. Using iVitality encouraged participants 
to think about their health and lifestyle: “iVitality made me 
more aware of the importance of a healthy lifestyle, including 
being and staying active” (protocol 1). Gaining information 
on one’s own health was equally or more important than 
contributing to scientific research for participants in OFG 1, 
although participants in OFG 2 indicated the contribution to 
scientific research as more important (or equal to personal 
health information). All participants believed that their 
privacy was guaranteed by iVitality and that the results dis-
played were accurate. Furthermore, participants in both focus 
groups agreed that they would contact their GP if iVitality 
indicated a high BP and some actually did this: “Via the iVi-
tality application, I received the notification that my BP was 
too high. So, I went to the doctor, but luckily no further action 
was required” (protocol 2). Participants in both focus groups 
had a somewhat negative view on the usability of iVitality. 
Participants indicated that the application sufficed for this 
study, but that improvements are needed in technical aspects 
(connection between BP measurement and smartphone, 
smartphone battery, restarting) and in the interface attractive-
ness. In OFG 1 half of the participants would have liked to 
continue their use of the iVitality application, while in OFG 2 
none of the participants preferred this. Participants in OFG 2 
would only continue their use of iVitality if feedback on the 
tests and games would be provided: “An added value would 
be to receive feedback regarding completed measurements. 
I would like to know in what way my own results compare 
to the standard” (protocol 2).
Discussion
This POP study evaluated the long-term acceptance and 
usability of iVitality according to children of people with 
dementia. It may be concluded that children of people with 
dementia accept iVitality after long-term use (6 months) 
and evaluated iVitality as a user-friendly, useful, and trusted 
technology, despite some technical and other suggestions 
for improvement. At T1 and T2, the level of acceptance 
and usability of iVitality did not differ between participants 
measuring health indicators monthly or fortnightly. When 
comparing acceptance and usability over time, participants 
conducting fortnightly health measurements showed a higher 
level of affection toward using iVitality at T2 compared to T1. 
The level of affection for iVitality of participants conducting 
monthly measurements did not change over time.
The results of this study are in line with the preliminary 
results of van Osch et al,5 who explored the usability of 
iVitality in four children of people with dementia, and 
showed the potential acceptance and usage of iVitality in 
larger user groups such as in this POP study. This finding 
is becoming more common in the light of the popularity of 
technology use and the increased uptake of innovative tech-
nologies by middle-aged adults.15 Middle-aged adults are 
getting used to technology and adopt and accept such tech-
nologies in health care settings more easily. This supports the 
potential of monitoring health indicators at home to prevent 
health problems, such as dementia. For example, some 
participants in this study contacted their GP when iVitality 
indicated a high BP and indicated that feedback on health 
data was very important. A suggestion for improvement was 
receiving feedback on the results displayed by iVitality and to 
be notified when further action is required. Such feedback is 
suggested to have the potential to influence patients’ attitudes 
and health behavior as well.16
Table 7 Participants’ activity on online focus group (OFg) forum
OFG 1 
(n=11)
OFG 2 
(n=15)
number of participants responding to all statements 2 6
number of participants responding to 9 statements 1 3
number of participants responding to 8 statements 2 0
number of participants responding to 7 statements 0 2
number of participants responding to 6 statements 2 0
number of participants responding to 5 statements 1 2
number of participants responding to 4 statements 1 1
number of participants responding to 3 statements 1 1
number of participants responding to 2 statements 1 0
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Attitude and behavior changes are of utmost importance 
for improving one’s health. In this light, the type of motiva-
tion for the use of self-management tools plays a role in the 
actual outcomes of using such tools. Intrinsic motivation has 
been associated with positive health outcomes.17 People’s own 
choice, insight into personal health data, and contributing to 
research were important reasons to use iVitality. Subjective 
norms of important others did not seem to play a role in the 
decision to participate. This suggests that the intrinsic moti-
vation to use iVitality was high among participants, while 
controlled motivation was low. Van Osch et al5 reported that 
the motivation to contribute to research might be a result 
of the unknown relation between dementia and hyperten-
sion, and indicated that addressing this relationship might 
stimulate self-monitoring. In addition to these motivations 
for self-monitoring, Wijsman et al18 monitored the adherence 
of participants of the POP study to the ascribed protocols. 
Overall, adherence to iVitality was acceptable (64%), 
although it was slightly better in participants measuring fort-
nightly (71.4%) compared to participants performing monthly 
measurements (64.3%). This rate of adherence is in agreement 
with previous research suggesting that motivation is the key 
to adherence with self-monitoring protocols.19–21 This study 
showed that participants measuring health indicators fort-
nightly showed a somewhat higher level of affection toward 
using iVitality over time. This is in line with the higher adher-
ence rates among participants with fortnightly health indica-
tor measurements reported by Wijsman et al.18 This finding 
should be put into perspective since all other acceptance and 
usability subscales did not differ between both measurement 
protocols, which indicates that acceptance and usability are 
fairly equal among participants measuring health indicators 
monthly and fortnightly. However, the slight preference for 
fortnightly health indicator measurements might be a result 
of participants developing a habit. Participants performing 
measurements more often (eg, fortnightly) may have been 
used to the procedure and may have experienced less burden 
due to the single-day measurements in comparison to the 
2-day monthly measurements. This might especially apply 
to the elderly, who often have to cope with forgetfulness. 
A strength of this study was that the monitoring and feedback 
system was tested in the daily environment of the participants, 
which makes the results more realistic and provides more 
accurate and detailed information into the experiences and 
problems that can occur. With regard to the methodology, 
credibility and confirmability were increased by data trian-
gulation. As participants were selected based on their pres-
ence in memory clinics at a certain time point, this may have 
introduced some selection bias. In addition, we did not mea-
sure information technology (IT) competences of participants, 
which might have influenced the acceptance and usability of 
iVitality. However, only participants in possession of a smart-
phone were included in the study. The findings also show that 
participants were highly motivated to participate, which may 
have influenced the results. Furthermore, response to the state-
ments of the OFGs was disappointing and the asynchronous 
aspect of the OFGs led to little communication between 
participants, which is considered as one of the limitations of 
asynchronous OFGs compared to traditional focus groups 
(TFGs). Better instructions or fixed time periods of response 
might have contributed to an increase in participant activ-
ity and interaction. However, the asynchronous aspect and 
absence of time pressure is often valued for its convenience, 
since participants are unconstrained by time and place.13,14 
Moreover, OFGs provide benefits to the researchers, since 
lower recruitment costs and travel expenses are required and 
researchers save time due to automatic capture of data. Pitfalls 
of OFGs compared to TFGs are potential sampling bias due 
to computer-illiteracy or misinterpretation of information due 
to the lack of non-verbal signals.13,14
The findings of this study in the light of previous research 
suggest that iVitality has the potential to be used in large-
scale clinical studies for home-based monitoring of health 
indicators related to the development of dementia, such as the 
PROBE study. The deployment of such a technology platform 
might contribute to the long-term monitoring of health indica-
tors in children of people with dementia, the relation of these 
health indicators with dementia, and therefore the prevention 
of dementia. Furthermore, iVitality might be used for home-
based monitoring among other patient groups for whom large-
scale studies with long follow-up periods are needed to show 
relations between health indicators and a disease. However, 
in order to realize the potential of iVitality in large-scale 
studies, a few issues should be addressed. Important sug-
gestions for improvement were more flexible measurement 
moments and receiving feedback on the results displayed in 
the application. Furthermore, some technical shortcomings 
influenced the perceived usability of iVitality.
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